Dr. David Bender, MD
Claim this profileUniversity of Iowa/Holden Comprehensive Cancer Center
Studies Adenocarcinoma
Studies Endometrioid Carcinoma
16 reported clinical trials
41 drugs studied
Area of expertise
1Adenocarcinoma
Stage IV
Stage III
Stage II
2Endometrioid Carcinoma
Stage IV
MMR negative
BRCA1 positive
Affiliated Hospitals
Clinical Trials David Bender, MD is currently running
Ipatasertib + Megestrol Acetate
for Endometrial Cancer
This trial is testing if combining two drugs, ipatasertib and megestrol acetate, is more effective than using megestrol acetate alone for treating women with endometrial cancer that has returned or spread. Ipatasertib blocks enzymes needed for cancer cell growth, while megestrol acetate reduces and blocks estrogen, which some cancer cells need to grow.
Recruiting1 award Phase 1 & 2
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
More about David Bender, MD
Clinical Trial Related1 year of experience running clinical trials · Led 16 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments David Bender, MD has experience with
- Olaparib
- Bevacizumab
- Pembrolizumab
- External Beam Radiation Therapy
- Cediranib Maleate
- Durvalumab
Breakdown of trials David Bender, MD has run
Adenocarcinoma
Endometrioid Carcinoma
Cancer
Ovarian Cancer
Serous Cystadenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Bender, MD specialize in?
David Bender, MD focuses on Adenocarcinoma and Endometrioid Carcinoma. In particular, much of their work with Adenocarcinoma has involved Stage IV patients, or patients who are Stage III.
Is David Bender, MD currently recruiting for clinical trials?
Yes, David Bender, MD is currently recruiting for 6 clinical trials in Iowa City Iowa. If you're interested in participating, you should apply.
Are there any treatments that David Bender, MD has studied deeply?
Yes, David Bender, MD has studied treatments such as Olaparib, Bevacizumab, Pembrolizumab.
What is the best way to schedule an appointment with David Bender, MD?
Apply for one of the trials that David Bender, MD is conducting.
What is the office address of David Bender, MD?
The office of David Bender, MD is located at: University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa 52242 United States. This is the address for their practice at the University of Iowa/Holden Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.